Medicare Enrolled

Dr. Yousef Abou-Allaban, MD

Psychiatry · Walpole, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
420 MAIN ST, Walpole, MA 02081
5086601666
In practice since 2006 (20 years)
NPI: 1922040666 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Abou-Allaban from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abou-Allaban? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Abou-Allaban

Dr. Yousef Abou-Allaban is a psychiatry specialist in Walpole, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Abou-Allaban performed 782 Medicare services across 224 unique beneficiaries.

Between the years covered by Open Payments, Dr. Abou-Allaban received a total of $39,931 from 30 pharmaceutical and/or device companies across 532 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Abou-Allaban is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 12% volume in MA $39,931 industry payments

Medicare Practice Summary

Medicare Utilization ↗
782
Medicare services
Top 12% in MA for psychiatry
224
Unique beneficiaries
$146
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~39 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Magnetic field treatment to stimulate brain nerve cells
A procedure using a magnetic field to stimulate nerve cells in the brain, including the delivery and management of the treatment.
352 $172 $600
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
264 $108 $300
Psychotherapy and evaluation, 30 minutes
A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes.
40 $55 $150
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
40 $155 $400
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
33 $128 $400
Magnetic brain stimulation with motor threshold determination
A procedure using magnetic fields to stimulate nerve cells in the brain. It includes determining the motor threshold and managing the delivery of the treatment.
22 $250 $1,000
New patient office visit, complex (60-74 min) 16 $191 $500
Magnetic field treatment to stimulate brain nerve cells, initial delivery
A procedure that uses a magnetic field to stimulate nerve cells in the brain. This code covers the initial delivery and management of the treatment.
15 $298 $800
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$39,931
Total received (2018-2024)
Avg $5,704/year across 7 years
Top 3% in MA for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
532
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$31,676 (79.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,255 (20.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$15,902
2023
$16,703
2022
$1,604
2021
$1,484
2020
$565
2019
$2,072
2018
$1,602

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$14,819
Teva Pharmaceuticals USA, Inc.
$272
Neurocrine Biosciences, Inc.
$175
Otsuka America Pharmaceutical, Inc.
$111
Alkermes, Inc.
$93
Tempus AI, Inc
$87
Lundbeck LLC
$82
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$74
ABBVIE INC.
$62
LivaNova USA, Inc.
$54
E.R. Squibb & Sons, L.L.C.
$30
Supernus Pharmaceuticals, Inc.
$23
Vanda Pharmaceuticals Inc.
$21
Top 3 companies account for 96.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$30,533
Otsuka America Pharmaceutical, Inc.
$2,244
Teva Pharmaceuticals USA, Inc.
$1,360
Neurocrine Biosciences, Inc.
$960
Lundbeck LLC
$631
Alkermes, Inc.
$527
Takeda Pharmaceuticals U.S.A., Inc.
$478
Allergan Inc.
$434
ITI, Inc.
$403
Vanda Pharmaceuticals Inc.
$395
AbbVie Inc.
$323
Sunovion Pharmaceuticals Inc.
$283
ABBVIE INC.
$214
Shire North American Group Inc
$176
Ironshore Pharmaceuticals Inc.
$128
Axsome Therapeutics, Inc.
$118
Corium, LLC
$118
Tempus AI, Inc
$87
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$74
Allergan, Inc.
$65
Neuronetics, Inc.
$63
LivaNova USA, Inc.
$54
ACADIA Pharmaceuticals Inc
$53
IDORSIA PHARMACEUTICALS US INC
$47
Supernus Pharmaceuticals, Inc.
$44
Almatica Pharma LLC
$33
E.R. Squibb & Sons, L.L.C.
$30
Bausch Health US, LLC
$25
ARBOR PHARMACEUTICALS, INC.
$16
Eisai Inc.
$14
Top 3 companies account for 85.5% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ABILIFY MYCITE · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Aristada 441 mg · Austedo XR · Auvelity · Azstarys · BRINTELLIX · CAPLYTA · DAYBUE · Dayvigo · Evekeo · FANAPT · GRALISE · HETLIOZ · Hetlioz · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · NEUROSTAR TMS THERAPY · QELBREE · QUVIVIQ · Qelbree · REXULTI · SPRAVATO · TRINTELLIX · Trintellix · UZEDY · VIVITROL · VNS THERAPY SYMMETRY MODEL 8103 GENERATOR · VRAYLAR · VYVANSE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (79%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in psychiatry and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for psychiatry in MA.

Looking for a psychiatry specialist in Walpole?
Compare psychiatrists in the Walpole area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
2,265
Per 100K population
312.6
County median income
$126,497
Nearest hospital
NORWOOD HOSPITAL
4.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Abou-Allaban is a clinical cardiology specialist, with above-average Medicare volume (top 12% in MA), with speaking/promotional industry engagement in the top 3% of MA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Abou-Allaban experienced with magnetic field treatment to stimulate brain nerve cells?
Based on Medicare claims data, Dr. Abou-Allaban performed 352 magnetic field treatment to stimulate brain nerve cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abou-Allaban receive payments from pharmaceutical companies?
Yes. Dr. Abou-Allaban received a total of $39,931 from 30 companies across 532 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abou-Allaban's costs compare to other psychiatrists in Walpole?
Dr. Abou-Allaban's average Medicare payment per service is $146. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abou-Allaban) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →